🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "focused action to address cost of living challenges" in the upcoming Budget.

In comments to media outlets, she noted that reducing price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Potential Utility Cost Measures

It is understood the government could intervene to lower utility costs, for example by cutting the present 5% level of value-added tax charged on energy.

Another possibility is to reduce some of the government charges currently included in bills.

Budgetary Constraints and Expert Predictions

The government will receive the latest report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for such measures.

The consensus from the majority of economists is that Reeves will have to declare higher taxes or expenditure reductions in order to adhere to her declared fiscal targets.

Earlier on Thursday, estimates suggested there was a £22 billion shortfall for the chancellor to resolve, which is at the more modest range of projections.

"It is a collective responsibility between the central bank and the administration to further reduce some of the drivers of inflation," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Tax Pledges and Global Concerns

While much of the attention has been on expected tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not changed her vow to campaign commitments not to increase tax levels on earnings tax, sales tax or social security contributions.

She attributed an "uncertain world" with increasing international and commercial issues for the Budget tax moves, probably to be focused on those "most able to pay."

Global Trade Tensions

Commenting on concerns about the UK's commercial links with China she said: "Our security interests always are paramount."

Recent statement by China to increase export controls on rare earths and other materials that are essential for advanced tech production led American leader Donald Trump to threaten an extra 100% import tax on imports from China, raising the possibility of an full-scale commercial conflict between the two economic giants.

The American finance chief called the Chinese decision "economic coercion" and "a international production control attempt."

Questioned on accepting the American proposal to participate in its dispute with the Asian nation, Reeves said she was "extremely troubled" by China's actions and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "bad for the world economy and causes additional challenges."

"It is my opinion there are sectors where we should challenge China, but there are also important opportunities to trade with China's economy, including financial services and other sectors of the economic system. We've got to maintain that balance correct."

The Treasury chief also affirmed she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the NHS spends on drugs could go up as a result of ongoing talks with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

A number of the biggest global drug companies have said recently that they are either pausing or canceling operations in the UK, with several blaming the insufficient payments they are receiving.

Recently, the government science advisor said the cost the NHS spends on medicines would need to go up to prevent businesses and drug research funding leaving the United Kingdom.

The Chancellor stated to the BBC: "We have seen due to the cost structure, that medical research, recent pharmaceuticals have not been available in the United Kingdom in the way that they are in other EU nations."

"Our aim is to ensure that individuals receiving care from the National Health Service are able to access the best essential treatments in the globe. And so we are examining this situation, and... aiming to attract increased investment into the UK."